Cyress

Cyress gehört Astellas Pharma Inc. mit Hauptsitz in Japan. Nein. Der letztliche Eigentümer von Cyress, Astellas Pharma Inc., hat seinen Hauptsitz in Japan, nicht in den USA.

Astellas Pharma is a multinational pharmaceutical company formed in 2005 through the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical. It focuses on several therapeutic areas including cardiology, urology, and oncology.

Bmodesto (Dutch distributor)